Advisory Services Network’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Advisory Services Network’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$253K	Sell	2,918 -1,290	-31%	-$113K	﹤0.01%	1680
2025 Q4	$357K	Buy	4,208 +30	+0.7%	+$2.39K	0.01%	1384
2025 Q3	$303K	Hold	4,178	–	–	﹤0.01%	1465
2025 Q2	$275K	Sell	4,178 -118	-3%	-$7.68K	﹤0.01%	1466
2025 Q1	$303K	Sell	4,296 -143	-3%	-$9.94K	0.01%	1289
2024 Q4	$292K	Buy	4,439 +293	+7%	+$20.2K	0.01%	1309
2024 Q3	$275K	Hold	4,146	–	–	0.01%	1243
2024 Q2	$275K	Hold	4,146	–	–	0.01%	1243
2024 Q1	$281K	Buy	4,146 +114	+3%	+$7.54K	0.01%	1175
2023 Q4	$249K	Hold	4,032	–	–	0.01%	1169
2023 Q3	$238K	Buy	4,032 +30	+0.7%	+$1.84K	0.01%	1243
2023 Q2	$239K	Sell	4,002 -123	-3%	-$7.31K	0.01%	1222
2023 Q1	$241K	Hold	4,125	–	–	0.01%	1225
2022 Q4	$256K	Buy	4,125 +6	+0.1%	+$361	0.01%	1152
2022 Q3	$233K	Sell	4,119 -321	-7%	-$19.8K	0.01%	1136
2022 Q2	$284K	Sell	4,440 -27	-0.6%	-$1.71K	0.01%	1093
2022 Q1	$289K	Hold	4,467	–	–	0.01%	1175
2021 Q4	$297K	Sell	4,467 -78	-2%	-$4.95K	0.01%	1133
2021 Q3	$277K	Hold	4,545	–	–	0.01%	1136
2021 Q2	$281K	Sell	4,545 -1,281	-22%	-$77.9K	0.01%	1119
2021 Q1	$345K	Hold	5,826	–	–	0.01%	967
2020 Q4	$348K	Buy	5,826 +5,262	+933%	+$300K	0.01%	877
2020 Q3	$31K	Buy	+564	New	+$30.4K	﹤0.01%	1838
2020 Q2	–	Sell	-600	Closed	-$27K	–	1857
2020 Q1	$27K	Sell	600 -48	-7%	-$2.42K	﹤0.01%	1694
2019 Q4	$35K	Buy	648 +117	+22%	+$5.77K	﹤0.01%	1695
2019 Q3	$27K	Hold	531	–	–	﹤0.01%	1657
2019 Q2	$27K	Hold	531	–	–	﹤0.01%	1655
2019 Q1	$27K	Hold	531	–	–	﹤0.01%	1487
2018 Q4	$25K	Sell	531 -411	-44%	-$21.1K	﹤0.01%	1403
2018 Q3	$53K	Hold	942	–	–	﹤0.01%	1203
2018 Q2	$50K	Hold	942	–	–	﹤0.01%	1210
2018 Q1	$46K	Sell	942 -3,249	-78%	-$167K	﹤0.01%	1353
2017 Q4	$216K	Sell	4,191 -147	-3%	-$7.55K	0.02%	746
2017 Q3	$226K	Sell	4,338 -4,197	-49%	-$215K	0.03%	622
2017 Q2	$441K	Sell	8,535 -96	-1%	-$4.85K	0.06%	412
2017 Q1	$434K	Buy	+8,631	New	+$427K	0.06%	386
2016 Q3	$443K	Sell	8,889 -555	-6%	-$28.1K	0.08%	330
2016 Q2	$455K	Sell	9,444 -135	-1%	-$6.42K	0.1%	275
2016 Q1	$437K	Sell	9,579 -129	-1%	-$6.04K	0.12%	218
2015 Q4	$523K	Sell	9,708 -27	-0.3%	-$1.42K	0.17%	150
2015 Q3	$480K	Buy	9,735 +474	+5%	+$27.2K	0.14%	154
2015 Q2	$543K	Buy	9,261 +8,436	+1,023%	+$493K	0.16%	148
2015 Q1	$47K	Hold	825	–	–	0.01%	507
2014 Q4	$43K	Buy	+825	New	+$40.2K	0.01%	450
2014 Q1	–	Sell	-825	Closed	-$32K	–	488
2013 Q4	$32K	Buy	+825	New	+$31K	0.02%	379

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

MSCM

McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ACM

Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Advisory Services Network's IHE Position: Q1 2026 in Review

Advisory Services Network reduced its iShares US Pharmaceuticals ETF (IHE) stake by 31% in Q1 2026, selling an estimated $113K and leaving 2,918 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

Advisory Services Network first reported a position in IHE in Q4 2013 and has held it in 45 quarters since. The position peaked at $543K in Q2 2015. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

Advisory Services Network held 2,918 shares of iShares US Pharmaceuticals ETF worth $253K as of Q1 2026.
Advisory Services Network sold 1,290 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $113K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #1680 holding.
Advisory Services Network first reported a position in iShares US Pharmaceuticals ETF in Q4 2013 and has held it in 45 quarters since.
Advisory Services Network's iShares US Pharmaceuticals ETF position peaked at $543K in Q2 2015.
194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.